Ammon Fager, MD, PhD, third-year research fellow (Hemtology and Oncology), has received a Young Investigator Translational Research award from the Center for Thrombotic and Hemostatic Disorders.
Dr. Fager will use the award to continue his research into how coagulation factor Vlla (rFViia) stops bleeding.
“We know factor VIIa is an effective drug used in hemophilia patients who have developed antibodies against other products, or to stop bleeding during heart surgery or bleeding in the brain, but we still don’t understand how it works,” Fager said.
Read the full article on the Duke Translational Medicine Institute website.